CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $79,563
- in 6 filings
Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-05 | Harrison Robert Gardner Chief Information Officer | Grant or award · Stock Option (right to buy) | +36,830 | 36,830 | ||
| 2025-03-05 | Boniface John J. Chief Scientific Officer | Grant or award | +47,010 | 172,894 | ||
| 2025-03-05 | Boniface John J. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +67,810 | 67,810 | ||
| 2025-03-05 | Aerts Austin Chief Financial Officer | Grant or award | +37,650 | 315,060 | ||
| 2025-03-05 | Aerts Austin Chief Financial Officer | Grant or award · Stock Option (right to buy) | +53,810 | 53,810 | ||
| 2025-02-13 | Harrison Robert Gardner Chief Information Officer | Sale 10b5-1 | −3,610 | $4.28 | $15K | 103,112 |
| 2025-02-13 | Jackson Benjamin General Counsel | Sale | −5,915 | $4.58 | $27K | 106,239 |
| 2025-02-12 | Mirza Mansoor Raza Director | Sale | −101 | $4.58 | $463 | 43,984 |
| 2025-02-12 | Lindgardt Zhenya Chief Executive Officer | Sale | −14,075 | $4.58 | $64K | 779,459 |
| 2025-02-12 | Kearney Paul Chief Data Officer | Sale | −5,342 | $4.58 | $24K | 158,128 |
| 2025-02-12 | Harrison Robert Gardner Chief Information Officer | Sale | −7,297 | $4.58 | $33K | 106,722 |
| 2025-02-12 | Boniface John J. Chief Scientific Officer | Sale | −5,915 | $4.58 | $27K | 125,884 |
| 2025-02-12 | Aerts Austin Chief Financial Officer | Sale | −5,915 | $4.58 | $27K | 277,410 |
| 2025-02-11 | Harrison Robert Gardner Chief Information Officer | Sale 10b5-1 | −554 | $3.97 | $2K | 114,019 |
| 2025-01-27 | Mirza Mansoor Raza Director | Option exercise | +37,549 | $0.91 | $34K | 44,085 |
| 2025-01-27 | Mirza Mansoor Raza Director | Option exercise · Stock Option (right to buy) | −37,549 | 0 | ||
| 2025-01-14 | Phillips Joshua Director | Sale 10b5-1 | −2 | $6.29 | $13 | 0 |
| 2025-01-14 | Phillips Joshua Director | Sale 10b5-1 | −4,827 | $6.29 | $30K | 0 |
| 2025-01-14 | Phillips Joshua Director | Sale 10b5-1 | −1,814 | $6.29 | $11K | 0 |
| 2025-01-14 | Phillips Joshua Director | Sale 10b5-1 | −2,695 | $6.29 | $17K | 0 |
Page 10 of 15 · 296 trades